Bemnifosbuvir hemisulfate

Description: Bemnifosbuvir hemisulfate (AT-527) is a potent inhibitor of HCV virus replication. Target: HCV Protease, SARS-CoV. Smiles: C[C@@H](C(OC(C)C)=O)N[P@@](OC1=CC=CC=C1)(OC[C@H]2O[C@@H](N3C=NC4=C(NC)N=C(N)N=C34)[C@](C)(F)[C@@H]2O)=O.C[C@@H](C(OC(C)C)=O)N[P@@](OC5=CC=CC=C5)(OC[C@H]6O[C@@H](N7C=NC8=C(NC)N=C(N)N=C78)[C@](C)(F)[C@@H]6O)=O.O=S(O)(O)=O. References: Good S S , Moussa A , Zhou X J , et al. Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus[J]. PLoS ONE, 2020, 15(1):e0227104-.